Non-PBS Prescriptions in Workers Compensation Claims
Understanding private prescriptions, identifying cost risks, and when to challenge non-PBS prescribing in insurance claims
Published: 4 April 2026
Introduction: What Are Non-PBS Prescriptions and Why They Matter
A non-PBS prescription is a private prescription that bypasses the Pharmaceutical Benefits Scheme (PBS). When a doctor issues a private prescription instead of a PBS prescription, the claimant is not entitled to the PBS subsidy. They pay the full, unsubsidised cost of the medication. For insurers and claims managers, non-PBS prescribing represents a cost management concern, a potential indicator of inappropriate prescribing, and an area where you should scrutinise clinical justification.
In workers compensation claims, non-PBS prescriptions are sometimes clinically justified (e.g., compounded medications, medications not listed on PBS, specific doses available only privately). In other cases, non-PBS prescribing signals that the prescriber is avoiding PBS authority requirements designed to ensure appropriate use, or is prescribing at doses or quantities that would not meet PBS authority criteria.
Your role as claims manager includes identifying non-PBS prescribing patterns and distinguishing between legitimate clinical use and inappropriate prescribing that costs insurers more without clinical benefit.
Key point: Non-PBS prescriptions are more expensive, harder to track, and sometimes used to circumvent authority requirements that protect against inappropriate prescribing. A pharmacy review can identify which non-PBS prescribing is clinically justified and which represents unnecessary cost or inappropriate use.
Understanding PBS and Non-PBS Prescriptions
What Is the PBS?
The Pharmaceutical Benefits Scheme is Australia's government-subsidised medication program. When a doctor issues a PBS prescription, the patient pays a concessional patient contribution (currently capped at around $42 for general patients). The government subsidy covers the remainder of the medication cost. This system ensures affordable access to medications while controlling government expenditure through authority requirements and restrictions.
PBS prescriptions require prescribers to follow specific rules: medications are listed only for approved indications, doses are specified, and for some medications, doctors must obtain authority from Services Australia before the patient can access the subsidy. These authority requirements protect against inappropriate use and off-label prescribing.
What Is a Non-PBS Prescription?
A non-PBS prescription is issued outside the PBS system. The patient pays the full, unsubsidised cost directly to the pharmacy. The prescriber has not requested subsidy; the patient bears the full financial burden.
Non-PBS prescriptions are legitimately used for medications not listed on the PBS, compounded medications (prepared specifically for an individual patient), doses available only privately, or situations where the patient chooses to access a medication without subsidy despite PBS availability.
The Cost Difference
The cost difference between PBS and non-PBS prescriptions can be significant. For example, a common medication might cost $12 with PBS subsidy but $50-100 for the non-PBS version. Over months or years, this cost difference becomes substantial. In workers compensation claims where you are funding medication, non-PBS prescribing inflates costs without necessarily providing better clinical outcomes.
When Non-PBS Prescribing Is Legitimate
Medications Not Listed on the PBS
Some medications, particularly newer medications, are not listed on the PBS. If a medication is not available on PBS, private prescribing is the only option. This is clinically legitimate when the medication addresses the claimant's clinical need and PBS alternatives are unavailable or clinically inappropriate.
Compounded Medications
Some patients require compounded medications: medicines prepared specifically for an individual by a pharmacist. These might be custom doses, formulations without additives the patient cannot tolerate, or combinations not available commercially. Compounded medications are not PBS-listed and must be prescribed privately. This prescribing is clinically legitimate when a commercially available PBS alternative would not meet the patient's clinical needs.
Specific Doses or Formulations
Occasionally, a claimant requires a dose or formulation available only in the private market. If a doctor determines that a specific private formulation is necessary (e.g., a dose strength not available in the PBS-listed version), private prescribing may be justified. However, this should be exceptional; most medications have PBS alternatives.
Patient Request Without Clinical Justification
Some patients request private prescriptions due to perceived quality differences, brand preferences, or pharmacy relationships. While patients have the right to request private prescriptions, as claims manager you are not obligated to fund private prescriptions when PBS alternatives are clinically equivalent. Your funding obligation extends to PBS-listed medications; private prescriptions are the claimant's responsibility unless clinically justified.
Red Flags: When Non-PBS Prescribing Suggests Inappropriate Treatment
Avoiding PBS Authority Requirements
Some medications on the PBS have authority restrictions. A doctor may seek authority to prescribe above the recommended dose, for an off-label indication, or for long-term therapy where PBS authority requires periodic review and reapplication. If a prescriber issues a private prescription instead of seeking PBS authority, they may be avoiding the authority requirement and the clinical justification it requires.
For example, opioid medications have PBS authority criteria limiting high-dose prescribing. If a doctor prescribes high-dose opioids via private prescription rather than seeking PBS authority, they are avoiding the clinical scrutiny that authority requires. This is a significant red flag for inappropriate prescribing.
Higher Quantities or Doses
Non-PBS prescriptions sometimes allow prescribing at doses or quantities higher than PBS authority would permit. If you notice non-PBS prescribing at higher-than-typical doses or quantities, investigate whether PBS prescribing at standard doses would be more appropriate.
Lack of Clinical Documentation
Legitimate non-PBS prescribing should be documented with clinical justification. If a prescriber cannot articulate why PBS prescribing would be inappropriate and why private prescribing is necessary, the prescribing is questionable. Request written justification; if none is provided, consider declining to fund the private prescription.
Prescribing Pattern Rather Than One-Off Situation
If non-PBS prescriptions are occasional and clearly justified, they may represent reasonable clinical decisions. If non-PBS prescribing is a pattern in the claimant's medication record, it may indicate systematic avoidance of PBS requirements or inappropriate prescribing patterns. A pharmacy review can identify whether non-PBS prescribing is justified or problematic.
Private Prescriptions for Low-Cost PBS Medications
If a medication is available on PBS at low cost, yet the prescriber issues a private prescription at high cost without clear justification, this raises suspicion. Why would the prescriber choose a more expensive, non-subsidised option without clinical justification? This pattern may indicate prescriber convenience, pharmacy relationships, or lack of engagement with the PBS system rather than clinical appropriateness.
| Non-PBS Medication Type | Typical Reason for Private Prescribing | Red Flags for Inappropriate Use | Claims Manager Action |
|---|---|---|---|
| Medication not on PBS list | No PBS availability; necessary for clinical condition | PBS alternative available but prescriber chose private version | Verify PBS unavailability; request clinical justification |
| Compounded medication | Custom dose, formulation for patient intolerance | Commercial PBS equivalent available and suitable | Request pharmacy report on compounding justification |
| High-dose opioids | Specific dose not in PBS-listed products | Private prescribing to avoid PBS authority review; dose above guidelines | Refer for pharmacy review; consider treatment refusal |
| Benzodiazepines at high dose or long-term | Rarely justified; usually indicates prescriber avoidance of authority | Private prescribing to avoid authority restriction on long-term use | Challenge prescribing; request PBS compliance or clinical justification |
| Private brand vs. generic | Patient or prescriber preference; rarely clinically necessary | Significantly higher cost for generic equivalent available on PBS | Request cost justification; decline funding if equivalent available |
| Over-the-counter medication purchased privately | Patient convenience; not requiring prescription | Should be patient responsibility; not worker compensation claim cost | Decline funding; clarify OTC medications are not insurer responsibility |
Cost Implications of Non-PBS Prescribing
Direct Cost Impact
Non-PBS prescribing inflates claims costs directly. Over a year, non-PBS prescriptions can cost thousands of dollars more than PBS equivalents. For your claims budget, identifying non-PBS prescribing and converting to PBS alternatives represents significant cost savings without clinical compromise.
Cumulative Impact
In a large claims portfolio, non-PBS prescribing patterns across many claimants represent substantial aggregate cost. Even if individual claimants' non-PBS costs seem small, the portfolio impact can be significant. Systematic review of non-PBS prescribing patterns can identify opportunities for cost reduction.
Claims Trajectory
Non-PBS prescribing sometimes signals broader prescribing concerns. Claimants on non-PBS opioids or benzodiazepines may be at higher risk of prolonged claims, delayed recovery, and escalating costs. Addressing non-PBS prescribing patterns may be part of broader claims optimisation strategy.
How Pharmacy Review Identifies and Assesses Non-PBS Prescribing
Systematic Review of Non-PBS Patterns
A pharmacy review examines all medications in the claimant's medication history and flags non-PBS prescribing. The reviewer identifies patterns: is non-PBS prescribing occasional or systematic? Does it involve specific medication classes (high-risk medications like opioids) or diverse medications?
Clinical Justification Assessment
For each non-PBS prescription, the reviewer assesses whether clinical justification exists. Is the medication genuinely unavailable on PBS? Would a PBS alternative be clinically suitable? Is the dose or formulation available only privately? The reviewer documents whether non-PBS prescribing is justified or questionable.
PBS Authority Compatibility
The reviewer considers whether the non-PBS prescribing appears designed to avoid PBS authority requirements. High-dose opioids, long-term benzodiazepines, or other medications typically requiring authority should prompt investigation: why is the prescriber avoiding the authority requirement? What does this indicate about the prescriber's confidence in the appropriateness of the prescribing?
Cost Analysis
The pharmacy review quantifies cost implications. It identifies the PBS equivalent cost vs. actual non-PBS cost, estimates annual cost difference, and projects savings if non-PBS prescribing could be converted to PBS alternatives. This financial analysis helps you prioritise which non-PBS prescriptions to challenge.
Your Response as Claims Manager: When to Challenge Non-PBS Prescribing
Request PBS Prescribing Instead
If a medication is available on PBS and clinically appropriate at PBS-listed doses, you should request the prescriber issue a PBS prescription instead of non-PBS. Frame this as cost management aligned with the claimant's interest: PBS prescribing reduces the claimant's out-of-pocket costs.
Communicate with the prescriber: "This medication is available on the PBS at a lower cost. Please issue a PBS prescription rather than non-PBS." Most prescribers will readily switch; some may explain why PBS prescribing is inappropriate (e.g., the dose required exceeds PBS authority). These explanations help you understand whether non-PBS prescribing is genuinely clinically necessary.
Request Clinical Justification
If the prescriber insists on non-PBS prescribing, request written clinical justification. Why is PBS prescribing inappropriate? What clinical feature of this patient necessitates private prescribing? Document the prescriber's response. This documentation protects you if the matter escalates to dispute or tribunal: you have evidence that you inquired about clinical justification rather than simply refusing to fund.
Decline Funding of Unjustified Non-PBS Prescriptions
If non-PBS prescribing lacks clinical justification, you are entitled to decline funding the private prescription and offer to fund the PBS equivalent instead. This is defensible on cost-management grounds grounded in clinical appropriateness. Your obligation under the Workers Compensation Act is to fund "reasonably necessary" treatment; non-PBS prescribing without clinical justification may not meet that threshold.
Refer for Pharmacy Review If Pattern Is Unclear
If you are uncertain whether non-PBS prescribing is clinically justified, refer for pharmacy review. The reviewer's assessment provides the clinical foundation for your decision. A pharmacy review stating that non-PBS prescribing lacks clinical justification strengthens your position if the matter becomes disputed.
Linking Non-PBS Prescribing Assessment to Broader Claims Management
Non-PBS prescribing patterns should be evaluated alongside other medication concerns. A claimant on non-PBS high-dose opioids may warrant broader medication review examining the entire regimen. A claimant with scattered non-PBS prescriptions for various purposes may indicate a prescriber not engaged with the PBS system.
Use non-PBS prescribing as a flag for pharmacy review referral. When you identify non-PBS prescribing, consider whether a comprehensive medication review is warranted to examine the full medication regimen for appropriateness, cost-effectiveness, and safety.
Documentation and Evidence
Keep clear records of:
- Non-PBS medications identified in the claimant's medication history
- Requests you made to the prescriber to switch to PBS prescribing
- Clinical justifications provided by the prescriber
- Your decision on whether to fund non-PBS prescriptions
- Cost implications and savings achieved by converting to PBS prescribing
- Pharmacy review findings regarding justification for non-PBS prescribing
This documentation demonstrates that your cost management decisions are grounded in clinical assessment, not arbitrary cost-cutting.
Key Takeaways for Claims Managers
Non-PBS prescribing represents a cost management opportunity grounded in clinical appropriateness. Legitimate non-PBS prescribing exists for medications truly unavailable on PBS or where clinical need justifies private prescribing. However, non-PBS prescribing without clinical justification inflates costs and sometimes signals inappropriate prescribing (particularly avoidance of PBS authority requirements).
Systematically review non-PBS prescribing patterns in your claims portfolio. Request PBS prescribing when alternatives are available and clinically appropriate. Request clinical justification when prescribers resist. Use pharmacy review to assess whether non-PBS prescribing is justified. This approach manages costs while maintaining clinical appropriateness and supporting evidence-based treatment.
Need to assess non-PBS prescribing patterns in your claims?
IMM pharmacy reviews identify non-PBS prescribing, assess clinical justification, and quantify cost implications. Our pharmacists provide the clinical analysis you need to manage costs while supporting appropriate treatment.
Learn about IMM non-PBS prescribing assessment
